For research use only. Not for use in humans.

Landogrozumab (Anti-GDF8 / Myostatin)

Synonyms: LY2495655 Cat.No.A2676

Landogrozumab (Anti-GDF8 / Myostatin) is an humanized monoclonal antibody targeting myostatin. It effectively improves muscle volume, hand grip strength and function and can be used for the research of muscle wasting disease. MW :150 KD.

Landogrozumab (Anti-GDF8 / Myostatin)

Quality Control

Mechanism of Action

Description	Landogrozumab (Anti-GDF8 / Myostatin) is an humanized monoclonal antibody targeting myostatin. It effectively improves muscle volume, hand grip strength and function and can be used for the research of muscle wasting disease. MW :150 KD.
References	[1] https://pubmed.ncbi.nlm.nih.gov/33495503/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	1391726-30-9
Molecular Weight	150
Isotype	Human IgG4SP
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100 mM Pro-Ac, 20mM Arg, pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.